Published in Genome Res on April 26, 2011
DNA methylation age of human tissues and cell types. Genome Biol (2013) 7.48
The Molecular Taxonomy of Primary Prostate Cancer. Cell (2015) 3.29
Batch effect correction for genome-wide methylation data with Illumina Infinium platform. BMC Med Genomics (2011) 1.84
DNA methylation alterations exhibit intraindividual stability and interindividual heterogeneity in prostate cancer metastases. Sci Transl Med (2013) 1.63
Tissue of origin determines cancer-associated CpG island promoter hypermethylation patterns. Genome Biol (2012) 1.63
DNA methyltransferases: a novel target for prevention and therapy. Front Oncol (2014) 1.62
CpG island hypermethylation frequently silences FILIP1L isoform 2 expression in prostate cancer. J Urol (2012) 1.56
Dietary Flavones as Dual Inhibitors of DNA Methyltransferases and Histone Methyltransferases. PLoS One (2016) 1.41
Translational genomics: the challenge of developing cancer biomarkers. Genome Res (2012) 1.26
Identification of new differentially methylated genes that have potential functional consequences in prostate cancer. PLoS One (2012) 1.15
Prognostic DNA methylation markers for prostate cancer. Int J Mol Sci (2014) 1.05
Genome-wide CpG island methylation analysis implicates novel genes in the pathogenesis of renal cell carcinoma. Epigenetics (2012) 1.04
DNA methylation profiles of airway epithelial cells and PBMCs from healthy, atopic and asthmatic children. PLoS One (2012) 1.04
Genome-wide methylation analysis of prostate tissues reveals global methylation patterns of prostate cancer. Am J Pathol (2013) 1.00
Long-range epigenetic silencing of chromosome 5q31 protocadherins is involved in early and late stages of colorectal tumorigenesis through modulation of oncogenic pathways. Oncogene (2012) 1.00
Dietary factors and epigenetic regulation for prostate cancer prevention. Adv Nutr (2011) 1.00
LRpath analysis reveals common pathways dysregulated via DNA methylation across cancer types. BMC Genomics (2012) 0.99
Prostate cancer - a biomarker perspective. Front Endocrinol (Lausanne) (2012) 0.97
Epigenomic alterations in localized and advanced prostate cancer. Neoplasia (2013) 0.96
DNA methylation, its mediators and genome integrity. Int J Biol Sci (2015) 0.96
Proteomic classification of acute leukemias by alignment-based quantitation of LC-MS/MS data sets. J Proteome Res (2012) 0.95
Heterogeneity of DNA methylation in multifocal prostate cancer. Virchows Arch (2014) 0.95
Mahanine restores RASSF1A expression by down-regulating DNMT1 and DNMT3B in prostate cancer cells. Mol Cancer (2013) 0.94
Epigenetic susceptibility factors for prostate cancer with aging. Prostate (2013) 0.94
DNA methylation profiling reveals novel diagnostic biomarkers in renal cell carcinoma. BMC Med (2014) 0.92
Adult porcine genome-wide DNA methylation patterns support pigs as a biomedical model. BMC Genomics (2015) 0.92
Hepcidin regulation in prostate and its disruption in prostate cancer. Cancer Res (2015) 0.91
Quantitative DNA methylation analysis of genes coding for kallikrein-related peptidases 6 and 10 as biomarkers for prostate cancer. Epigenetics (2012) 0.88
Genome-wide DNA methylation profiling of cell-free serum DNA in esophageal adenocarcinoma and Barrett esophagus. Neoplasia (2012) 0.88
The genomic landscape of prostate cancer. Int J Mol Sci (2013) 0.88
iCar-PseCp: identify carbonylation sites in proteins by Monte Carlo sampling and incorporating sequence coupled effects into general PseAAC. Oncotarget (2016) 0.88
MicroRNA profiling of novel African American and Caucasian Prostate Cancer cell lines reveals a reciprocal regulatory relationship of miR-152 and DNA methyltranferase 1. Oncotarget (2014) 0.87
Comparative DNA methylome analysis of endometrial carcinoma reveals complex and distinct deregulation of cancer promoters and enhancers. BMC Genomics (2014) 0.86
Genistein increases estrogen receptor beta expression in prostate cancer via reducing its promoter methylation. J Steroid Biochem Mol Biol (2015) 0.85
Interrogating genomic and epigenomic data to understand prostate cancer. Biochim Biophys Acta (2012) 0.85
Validation study of genes with hypermethylated promoter regions associated with prostate cancer recurrence. Cancer Epidemiol Biomarkers Prev (2014) 0.85
iPhos-PseEn: identifying phosphorylation sites in proteins by fusing different pseudo components into an ensemble classifier. Oncotarget (2016) 0.84
Even-skipped homeobox 1 is frequently hypermethylated in prostate cancer and predicts PSA recurrence. Br J Cancer (2012) 0.84
DNA methyltransferase inhibitor zebularine inhibits human hepatic carcinoma cells proliferation and induces apoptosis. PLoS One (2013) 0.83
Genome-wide analysis of DNA methylation in pigs using reduced representation bisulfite sequencing. DNA Res (2015) 0.82
Immortality, but not oncogenic transformation, of primary human cells leads to epigenetic reprogramming of DNA methylation and gene expression. Nucleic Acids Res (2013) 0.81
Regulation of lineage specific DNA hypomethylation in mouse trophectoderm. PLoS One (2013) 0.81
Inhibition of EZH2 by chemo- and radiotherapy agents and small molecule inhibitors induces cell death in castration-resistant prostate cancer. Oncotarget (2016) 0.81
DNA hypermethylation in prostate cancer is a consequence of aberrant epithelial differentiation and hyperproliferation. Cell Death Differ (2014) 0.80
Epigenomic profiling of DNA methylation in paired prostate cancer versus adjacent benign tissue. Prostate (2015) 0.80
Frequent disruption of chromodomain helicase DNA-binding protein 8 (CHD8) and functionally associated chromatin regulators in prostate cancer. Neoplasia (2014) 0.80
DNA Methylation-Guided Prediction of Clinical Failure in High-Risk Prostate Cancer. PLoS One (2015) 0.79
Effective identification of Gram-negative bacterial type III secreted effectors using position-specific residue conservation profiles. PLoS One (2013) 0.79
A panel of DNA methylation markers reveals extensive methylation in histologically benign prostate biopsy cores from cancer patients. Biomark Res (2014) 0.78
The role of microRNAs in prostate cancer progression. Transl Androl Urol (2013) 0.77
Small RNA-mediated DNA (cytosine-5) methyltransferase 1 inhibition leads to aberrant DNA methylation. Nucleic Acids Res (2015) 0.77
Analysis of Matched Tumor and Normal Profiles Reveals Common Transcriptional and Epigenetic Signals Shared across Cancer Types. PLoS One (2015) 0.77
Genome-wide profiling of DNA methylation and gene expression in esophageal squamous cell carcinoma. Oncotarget (2016) 0.77
Diagnostic and prognostic utility of a DNA hypermethylated gene signature in prostate cancer. PLoS One (2014) 0.77
Methylome-wide Sequencing Detects DNA Hypermethylation Distinguishing Indolent from Aggressive Prostate Cancer. Cell Rep (2015) 0.77
DNA Methyltransferase Activity Assays: Advances and Challenges. Theranostics (2016) 0.76
Integrating multi-omics for uncovering the architecture of cross-talking pathways in breast cancer. PLoS One (2014) 0.76
Loss of MEN1 activates DNMT1 implicating DNA hypermethylation as a driver of MEN1 tumorigenesis. Oncotarget (2016) 0.76
Defining the radiobiology of prostate cancer progression: An important question in translational prostate cancer research. Exp Biol Med (Maywood) (2014) 0.75
A novel method for identification and quantification of consistently differentially methylated regions. PLoS One (2014) 0.75
DNA methyltransferases and their roles in tumorigenesis. Biomark Res (2017) 0.75
DNA methylome and the complexity of discovering prostate cancer biomarkers. Asian J Androl (2011) 0.75
DNA methyltransferase inhibitor zebularine induces human cholangiocarcinoma cell death through alteration of DNA methylation status. PLoS One (2015) 0.75
A Magnetic Bead-Based Sensor for the Quantification of Multiple Prostate Cancer Biomarkers. PLoS One (2015) 0.75
Genome-wide DNA methylation measurements in prostate tissues uncovers novel prostate cancer diagnostic biomarkers and transcription factor binding patterns. BMC Cancer (2017) 0.75
One-Carbon Metabolism in Prostate Cancer: The Role of Androgen Signaling. Int J Mol Sci (2016) 0.75
Zfp296 negatively regulates H3K9 methylation in embryonic development as a component of heterochromatin. Sci Rep (2017) 0.75
The landscape of DNA methylation-mediated regulation of long non-coding RNAs in breast cancer. Oncotarget (2017) 0.75
Promoter DNA methylation analysis reveals a combined diagnosis of CpG-based biomarker for prostate cancer. Oncotarget (2017) 0.75
Significance analysis of microarrays applied to the ionizing radiation response. Proc Natl Acad Sci U S A (2001) 132.88
Cancer statistics, 2010. CA Cancer J Clin (2010) 103.28
Comprehensive genomic characterization defines human glioblastoma genes and core pathways. Nature (2008) 75.40
Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer. Science (2005) 39.06
Screening and prostate-cancer mortality in a randomized European study. N Engl J Med (2009) 35.94
Diagnosis of multiple cancer types by shrunken centroids of gene expression. Proc Natl Acad Sci U S A (2002) 30.32
Mortality results from a randomized prostate-cancer screening trial. N Engl J Med (2009) 30.05
DNA methyltransferases Dnmt3a and Dnmt3b are essential for de novo methylation and mammalian development. Cell (1999) 25.75
Integrative genomic profiling of human prostate cancer. Cancer Cell (2010) 23.61
Adjusting batch effects in microarray expression data using empirical Bayes methods. Biostatistics (2006) 22.61
The human colon cancer methylome shows similar hypo- and hypermethylation at conserved tissue-specific CpG island shores. Nat Genet (2009) 18.90
Gene expression correlates of clinical prostate cancer behavior. Cancer Cell (2002) 16.27
Identification of a CpG island methylator phenotype that defines a distinct subgroup of glioma. Cancer Cell (2010) 16.12
DNMT3A mutations in acute myeloid leukemia. N Engl J Med (2010) 14.07
Gene expression profiling identifies clinically relevant subtypes of prostate cancer. Proc Natl Acad Sci U S A (2004) 10.99
Hypomethylation distinguishes genes of some human cancers from their normal counterparts. Nature (1983) 9.28
Risk of prostate cancer-specific mortality following biochemical recurrence after radical prostatectomy. JAMA (2005) 8.72
Reduced representation bisulfite sequencing for comparative high-resolution DNA methylation analysis. Nucleic Acids Res (2005) 8.69
DNA methylation in cancer: too much, but also too little. Oncogene (2002) 6.96
Reprogramming towards pluripotency requires AID-dependent DNA demethylation. Nature (2010) 6.20
Cooperativity of TMPRSS2-ERG with PI3-kinase pathway activation in prostate oncogenesis. Nat Genet (2009) 5.31
Human DNA-(cytosine-5) methyltransferase-PCNA complex as a target for p21WAF1. Science (1997) 5.05
DNA methylation and cancer. J Clin Oncol (2004) 4.58
Prediction of novel families of enzymes involved in oxidative and other complex modifications of bases in nucleic acids. Cell Cycle (2009) 4.14
Aberrant patterns of DNA methylation, chromatin formation and gene expression in cancer. Hum Mol Genet (2001) 3.96
Aberrant methylation of p16(INK4a) is an early event in lung cancer and a potential biomarker for early diagnosis. Proc Natl Acad Sci U S A (1998) 3.80
The 5-methylcytosine content of DNA from human tumors. Nucleic Acids Res (1983) 3.51
A role for the elongator complex in zygotic paternal genome demethylation. Nature (2010) 3.27
Cytidine methylation of regulatory sequences near the pi-class glutathione S-transferase gene accompanies human prostatic carcinogenesis. Proc Natl Acad Sci U S A (1994) 3.24
An overview of the MAGE gene family with the identification of all human members of the family. Cancer Res (2001) 3.08
Cancer as an epigenetic disease: DNA methylation and chromatin alterations in human tumours. J Pathol (2002) 3.00
The role of SPINK1 in ETS rearrangement-negative prostate cancers. Cancer Cell (2008) 2.87
DNA methylation and cancer. Hum Mol Genet (1994) 2.84
The role of DNA methylation in cancer genetic and epigenetics. Annu Rev Genet (1996) 2.63
Distinct DNA methylation changes highly correlated with chronological age in the human brain. Hum Mol Genet (2011) 2.62
Discovery of non-ETS gene fusions in human prostate cancer using next-generation RNA sequencing. Genome Res (2010) 2.50
Copy number and targeted mutational analysis reveals novel somatic events in metastatic prostate tumors. Genome Res (2010) 2.41
Molecular sampling of prostate cancer: a dilemma for predicting disease progression. BMC Med Genomics (2010) 2.40
Physical and functional interactions between the human DNMT3L protein and members of the de novo methyltransferase family. J Cell Biochem (2005) 2.27
DNA methylation in serum of breast cancer patients: an independent prognostic marker. Cancer Res (2003) 2.14
A quantitative promoter methylation profile of prostate cancer. Clin Cancer Res (2004) 2.06
DNA methyltransferase and demethylase in human prostate cancer. Mol Carcinog (2002) 1.83
Methylation of the RUNX3 promoter as a potential prognostic marker for bladder tumor. J Urol (2008) 1.75
Human maintenance DNA (cytosine-5)-methyltransferase and p53 modulate expression of p53-repressed promoters. Proc Natl Acad Sci U S A (2005) 1.67
Molecular detection of prostate cancer in urine by GSTP1 hypermethylation. Clin Cancer Res (2001) 1.63
GSTP1 CpG island hypermethylation is responsible for the absence of GSTP1 expression in human prostate cancer cells. Am J Pathol (2001) 1.60
Co-expression of de novo DNA methyltransferases Dnmt3a2 and Dnmt3L in gonocytes of mouse embryos. Gene Expr Patterns (2004) 1.59
CG island methylation changes near the GSTP1 gene in prostatic intraepithelial neoplasia. Cancer Epidemiol Biomarkers Prev (1998) 1.59
GSTP1 CpG island hypermethylation as a molecular biomarker for prostate cancer. J Cell Biochem (2004) 1.58
DNA methylation and cancer. Cancer Res (1986) 1.47
Discovery of novel hypermethylated genes in prostate cancer using genomic CpG island microarrays. PLoS One (2009) 1.28
Association of tissue promoter methylation levels of APC, TGFβ2, HOXD3 and RASSF1A with prostate cancer progression. Int J Cancer (2011) 1.25
The usefulness of the detection of GSTP1 methylation in urine as a biomarker in the diagnosis of prostate cancer. J Urol (2008) 1.10
Expression changes in EZH2, but not in BMI-1, SIRT1, DNMT1 or DNMT3B are associated with DNA methylation changes in prostate cancer. Cancer Biol Ther (2007) 1.05
DNA methylation of HOXD3 as a marker of prostate cancer progression. Lab Invest (2010) 1.01
The contribution of genetic and epigenetic mechanisms to gene silencing in oligodendrogliomas. Cancer Res (2003) 0.99
A systematic search for DNA methyltransferase polymorphisms reveals a rare DNMT3L variant associated with subtelomeric hypomethylation. Hum Mol Genet (2009) 0.98
DNA methylation and methylase levels in normal and malignant mouse hepatic tissues. Carcinogenesis (1981) 0.96
Global DNA methylation: a common early event in oral cancer cases with exposure to environmental carcinogens or viral agents. P R Health Sci J (2009) 0.87
Overexpression of ZNF342 by juxtaposition with MPO promoter/enhancer in the novel translocation t(17;19)(q23;q13.32) in pediatric acute myeloid leukemia and analysis of ZNF342 expression in leukemia. Genes Chromosomes Cancer (2009) 0.78
Identification and analysis of functional elements in 1% of the human genome by the ENCODE pilot project. Nature (2007) 75.09
Genome-wide mapping of in vivo protein-DNA interactions. Science (2007) 64.92
Model-based analysis of ChIP-Seq (MACS). Genome Biol (2008) 51.63
Association analyses of 249,796 individuals reveal 18 new loci associated with body mass index. Nat Genet (2010) 23.08
Worldwide human relationships inferred from genome-wide patterns of variation. Science (2008) 22.44
Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences. Proc Natl Acad Sci U S A (2002) 20.48
GO::TermFinder--open source software for accessing Gene Ontology information and finding significantly enriched Gene Ontology terms associated with a list of genes. Bioinformatics (2004) 20.23
Evolving gene/transcript definitions significantly alter the interpretation of GeneChip data. Nucleic Acids Res (2005) 17.58
Identification of genes periodically expressed in the human cell cycle and their expression in tumors. Mol Biol Cell (2002) 17.32
Design and implementation of microarray gene expression markup language (MAGE-ML). Genome Biol (2002) 16.75
An integrated software system for analyzing ChIP-chip and ChIP-seq data. Nat Biotechnol (2008) 13.96
The prognostic role of a gene signature from tumorigenic breast-cancer cells. N Engl J Med (2007) 13.39
Genome-wide analysis of transcription factor binding sites based on ChIP-Seq data. Nat Methods (2008) 11.61
Gene expression profiling identifies clinically relevant subtypes of prostate cancer. Proc Natl Acad Sci U S A (2004) 10.99
Saccharomyces Genome Database (SGD) provides secondary gene annotation using the Gene Ontology (GO). Nucleic Acids Res (2002) 10.65
Widespread parallel evolution in sticklebacks by repeated fixation of Ectodysplasin alleles. Science (2005) 10.46
SOURCE: a unified genomic resource of functional annotations, ontologies, and gene expression data. Nucleic Acids Res (2003) 10.28
The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC). Genome Res (2004) 9.18
ChIP-seq guidelines and practices of the ENCODE and modENCODE consortia. Genome Res (2012) 9.13
Signals of recent positive selection in a worldwide sample of human populations. Genome Res (2009) 8.38
Genetic relationship between five psychiatric disorders estimated from genome-wide SNPs. Nat Genet (2013) 8.02
A simple spreadsheet-based, MIAME-supportive format for microarray data: MAGE-TAB. BMC Bioinformatics (2006) 7.53
Sequence census methods for functional genomics. Nat Methods (2007) 7.38
Molecular characterisation of soft tissue tumours: a gene expression study. Lancet (2002) 7.05
Population analysis of large copy number variants and hotspots of human genetic disease. Am J Hum Genet (2009) 6.79
The Stanford Microarray Database: data access and quality assessment tools. Nucleic Acids Res (2003) 6.31
Identification and functional analysis of human transcriptional promoters. Genome Res (2003) 6.23
An abundance of bidirectional promoters in the human genome. Genome Res (2004) 5.90
Evolution of pathogenicity and sexual reproduction in eight Candida genomes. Nature (2009) 5.90
Adaptive evolution of pelvic reduction in sticklebacks by recurrent deletion of a Pitx1 enhancer. Science (2009) 5.64
The genomic basis of adaptive evolution in threespine sticklebacks. Nature (2012) 5.20
A validated regulatory network for Th17 cell specification. Cell (2012) 4.82
Sequence features and chromatin structure around the genomic regions bound by 119 human transcription factors. Genome Res (2012) 4.80
Candidate-gene approaches for studying complex genetic traits: practical considerations. Nat Rev Genet (2002) 4.76
Gene expression patterns in human embryonic stem cells and human pluripotent germ cell tumors. Proc Natl Acad Sci U S A (2003) 4.67
Coding potential of laboratory and clinical strains of human cytomegalovirus. Proc Natl Acad Sci U S A (2003) 4.37
Prominent use of distal 5' transcription start sites and discovery of a large number of additional exons in ENCODE regions. Genome Res (2007) 4.33
The Stanford Microarray Database accommodates additional microarray platforms and data formats. Nucleic Acids Res (2005) 4.17
Standards for microarray data. Science (2002) 4.11
Distinct DNA methylation patterns characterize differentiated human embryonic stem cells and developing human fetal liver. Genome Res (2009) 4.11
Systematic evaluation of variability in ChIP-chip experiments using predefined DNA targets. Genome Res (2008) 4.08
Ribosomal mutations cause p53-mediated dark skin and pleiotropic effects. Nat Genet (2008) 4.02
GC-content normalization for RNA-Seq data. BMC Bioinformatics (2011) 3.89
Comprehensive analysis of transcriptional promoter structure and function in 1% of the human genome. Genome Res (2005) 3.85
Submission of microarray data to public repositories. PLoS Biol (2004) 3.83
Molecular Stratification of Clear Cell Renal Cell Carcinoma by Consensus Clustering Reveals Distinct Subtypes and Survival Patterns. Genes Cancer (2010) 3.78
Novel low abundance and transient RNAs in yeast revealed by tiling microarrays and ultra high-throughput sequencing are not conserved across closely related yeast species. PLoS Genet (2008) 3.69
A transcriptional profile of aging in the human kidney. PLoS Biol (2004) 3.69
Direct isolation and identification of promoters in the human genome. Genome Res (2005) 3.68
The Stanford Microarray Database: implementation of new analysis tools and open source release of software. Nucleic Acids Res (2006) 3.66
Dynamic DNA methylation across diverse human cell lines and tissues. Genome Res (2013) 3.61
Isolation and molecular characterization of cancer stem cells in MMTV-Wnt-1 murine breast tumors. Stem Cells (2007) 3.60
Genome-wide association and meta-analysis of bipolar disorder in individuals of European ancestry. Proc Natl Acad Sci U S A (2009) 3.49
Minimum information specification for in situ hybridization and immunohistochemistry experiments (MISFISHIE). Nat Biotechnol (2008) 3.43
The role of geography in human adaptation. PLoS Genet (2009) 3.41
Defining functional DNA elements in the human genome. Proc Natl Acad Sci U S A (2014) 3.35
Genomic determination of the glucocorticoid response reveals unexpected mechanisms of gene regulation. Genome Res (2009) 3.30
Comparative genomics modeling of the NRSF/REST repressor network: from single conserved sites to genome-wide repertoire. Genome Res (2006) 3.23
Stereotactic body radiotherapy for localized prostate cancer: interim results of a prospective phase II clinical trial. Int J Radiat Oncol Biol Phys (2008) 3.22
Standards for microarray data: an open letter. Environ Health Perspect (2004) 3.15
Genomic profiling reveals alternative genetic pathways of prostate tumorigenesis. Cancer Res (2007) 3.13
A human-curated annotation of the Candida albicans genome. PLoS Genet (2005) 3.04
Diverse and specific gene expression responses to stresses in cultured human cells. Mol Biol Cell (2004) 3.02
Molecular characterization of clonal interference during adaptive evolution in asexual populations of Saccharomyces cerevisiae. Nat Genet (2008) 2.98
The master sex-determination locus in threespine sticklebacks is on a nascent Y chromosome. Curr Biol (2004) 2.90
Transcriptional programs activated by exposure of human prostate cancer cells to androgen. Genome Biol (2002) 2.87
The underlying principles of scientific publication. Bioinformatics (2002) 2.79
High throughput sequencing reveals a complex pattern of dynamic interrelationships among human T cell subsets. Proc Natl Acad Sci U S A (2010) 2.74
TB database: an integrated platform for tuberculosis research. Nucleic Acids Res (2008) 2.71
Polymorphisms within the C-reactive protein (CRP) promoter region are associated with plasma CRP levels. Am J Hum Genet (2005) 2.71
Susceptibility locus for clinical and subclinical coronary artery disease at chromosome 9p21 in the multi-ethnic ADVANCE study. Hum Mol Genet (2008) 2.71
Urinary TMPRSS2:ERG and PCA3 in an active surveillance cohort: results from a baseline analysis in the Canary Prostate Active Surveillance Study. Clin Cancer Res (2013) 2.70
Rnnotator: an automated de novo transcriptome assembly pipeline from stranded RNA-Seq reads. BMC Genomics (2010) 2.62
Gene expression patterns in renal cell carcinoma assessed by complementary DNA microarray. Am J Pathol (2003) 2.59
Long-term outcomes from a prospective trial of stereotactic body radiotherapy for low-risk prostate cancer. Int J Radiat Oncol Biol Phys (2011) 2.57
Gene expression profiling predicts survival in conventional renal cell carcinoma. PLoS Med (2005) 2.56
The role of heat shock transcription factor 1 in the genome-wide regulation of the mammalian heat shock response. Mol Biol Cell (2003) 2.56
The Longhorn Array Database (LAD): an open-source, MIAME compliant implementation of the Stanford Microarray Database (SMD). BMC Bioinformatics (2003) 2.54
Effect of agonal and postmortem factors on gene expression profile: quality control in microarray analyses of postmortem human brain. Biol Psychiatry (2004) 2.53
A variant TMPRSS2 isoform and ERG fusion product in prostate cancer with implications for molecular diagnosis. Mod Pathol (2007) 2.47
Widespread plasticity in CTCF occupancy linked to DNA methylation. Genome Res (2012) 2.45
Analysis of DNA methylation in a three-generation family reveals widespread genetic influence on epigenetic regulation. PLoS Genet (2011) 2.41
Transcription factor binding and modified histones in human bidirectional promoters. Genome Res (2007) 2.40
Reply: whole-culture synchronization - effective tools for cell cycle studies. Trends Biotechnol (2004) 2.38
Comprehensive annotation of the transcriptome of the human fungal pathogen Candida albicans using RNA-seq. Genome Res (2010) 2.34
Systematic changes in gene expression in postmortem human brains associated with tissue pH and terminal medical conditions. Hum Mol Genet (2004) 2.33
Systematic evaluation of factors influencing ChIP-seq fidelity. Nat Methods (2012) 2.31
Evolutionary constraint facilitates interpretation of genetic variation in resequenced human genomes. Genome Res (2010) 2.31
Genomic patterns of homozygosity in worldwide human populations. Am J Hum Genet (2012) 2.30
Selective disruption of lysosomes in HeLa cells triggers apoptosis mediated by cleavage of Bid by multiple papain-like lysosomal cathepsins. J Biol Chem (2003) 2.30
The DNA sequence and biology of human chromosome 19. Nature (2004) 2.29
Quality assessment of the human genome sequence. Nature (2004) 2.29
Generation and annotation of the DNA sequences of human chromosomes 2 and 4. Nature (2005) 2.27
From single-cell to cell-pool transcriptomes: stochasticity in gene expression and RNA splicing. Genome Res (2013) 2.23
Rapid mapping of zebrafish mutations with SNPs and oligonucleotide microarrays. Genome Res (2002) 2.22
The completion of the Mammalian Gene Collection (MGC). Genome Res (2009) 2.21